Atrium Therapeutics awards new hire options for 13,500 shares, RSUs for 6,750 shares under inducement plan
Bitget2026/09/21 20:30- Atrium Therapeutics awarded inducement equity grants on Sept. 20, 2026 to one newly hired non-executive under its 2026 Employment Inducement Incentive Award Plan.
- Grant included non-qualified stock options for 13,500 shares with an exercise price of USD 8.95.
- Options vest 25% after one year, then monthly over 36 months, subject to continued service.
- Grant also included 6,750 restricted stock units, vesting 25% after one year, then annually over three years.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Ekopak Expands Wastewater Treatment Plant at Mark Anthony Brewing
Vodafone (VOD.US) Swings to Loss in First Half, German Operations Major Drag
Vodafone (VOD.US) released its financial results for the first half of fiscal year 2027.
AI gamble backfires! Data center project writedowns and weak tech stock positions drag down SoftBank (SFTBY.US) to a Q2 loss of $7.1 billion
SoftBank recorded its first net loss in nearly two years due to a $3.7 billion impairment loss arising from a U.S. data center project, coupled with mounting market concerns over the sustainability of artificial intelligence (AI) growth impacting the investment giant’s key holdings.
AI Cloud Sector Faces a Key Moment: CoreWeave (CRWV.US) Set to Announce Earnings, Wells Fargo Remains Bullish
CoreWeave (CRWV.US) will release its third-quarter financial report after the U.S. stock market closes on Tuesday. This is seen as a key test for the strength of the new AI cloud sector.
Crypto prices
More
